Retrovirus Models of Lymphocyte Transformation and Disease

淋巴细胞转化和疾病的逆转录病毒模型

基本信息

  • 批准号:
    7876682
  • 负责人:
  • 金额:
    $ 215.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-21 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This competitive renewal application of P01 CA100730 seeks funds to continue the study of highly integrated retrovirus models to elucidate essential cellular mechanisms that define lymphocyte transformation and disease. The study of retroviruses has provided fundamental and critical knowledge for defining the mechanisms of cell transformation as well as fundamental paradigms of cell biology. The interactive nature, established record of collaborations, and focus of the individual projects and cores that constitute the proposed PPG continuation are directly supportive of NCI's strategic plans and goals. Our goals were realized with robust productivity over the last four years demonstrated by 64 peer-reviewed manuscripts 70% interactive between PPG investigators. The continuation of the Program will extend upon the established interactions through inter-related goals to define critical events that control the transition of lymphocytes from activation through immortalization and transformation. Project 1 uses retroviruses to provide novel insights into how they alter transcription and DNA damage/repair signaling to establish persistent infections and set the stage for cellular transformation. Project 2 (Dr. Green) will define novel post-transcriptional mechanisms of retroviruses and working together with Dr. Lairmore (Project 1), will comparatively test each protein in viral replication and lymphocyte transformation. Project 3 working collaboratively with multiple PPG investigators will examine the fundamental translational control mechanisms in both retroviruses and in crucial growth control genes. Project 4 (Drs. Weilbaecher, Washington University and Rosol, Ohio State University) combine their expertise with PPG investigators to study the role of bone microenvironment in osteolytic and osteoblastic tumor models. Project 5 (Dr. Ratner) continues the highly dynamic collaborations between each University to test the contribution of the inflammatory microenvironment in carcinogenesis using unique transgenic mouse models. The PPG consists of five interactive Projects and three highly supportive Cores. Each project is related to two central components involving the regulation of lymphocyte signaling and gene expression by retroviruses or alterations of the cellular microenvironment leading to transformation and paraneoplastic disease. The interactive nature of the PPG will provide rationale hypotheses to support translational studies to define therapeutic intervention against retrovirus-induced lymphoma and refine animal models to determine molecular determinants of retrovirus-induced cancer.
描述(由申请人提供):P01 CA 100730的竞争性更新申请寻求资金,以继续研究高度整合的逆转录病毒模型,以阐明定义淋巴细胞转化和疾病的基本细胞机制。逆转录病毒的研究为确定细胞转化机制以及细胞生物学的基本范式提供了基础和关键知识。互动的性质,建立合作记录,以及构成拟议PPG延续的个别项目和核心的重点直接支持NCI的战略计划和目标。在过去的四年里,我们的目标以强大的生产力实现了,64篇同行评审的手稿证明了PPG研究者之间70%的互动。该计划的继续将通过相互关联的目标扩展到已建立的相互作用,以定义控制淋巴细胞从激活到永生化和转化的关键事件。项目1使用逆转录病毒来提供新的见解,了解它们如何改变转录和DNA损伤/修复信号,以建立持续性感染并为细胞转化奠定基础。项目2(绿色博士)将定义逆转录病毒的新的转录后机制,并与Lairmore博士(项目1)合作,将比较测试病毒复制和淋巴细胞转化中的每种蛋白质。项目3将与多个PPG研究人员合作,研究逆转录病毒和关键生长控制基因的基本翻译控制机制。项目4(Weilbaecher博士,华盛顿大学和Rosol博士,俄亥俄州州立大学)将他们的专业知识与PPG研究人员相结合,研究骨微环境在溶骨性和成骨细胞肿瘤模型中的作用。项目5(Ratner博士)继续了每所大学之间的高度动态合作,使用独特的转基因小鼠模型测试炎症微环境在致癌作用中的作用。PPG由五个互动项目和三个高度支持的核心组成。每个项目都涉及两个核心组成部分,涉及逆转录病毒对淋巴细胞信号传导和基因表达的调节或导致转化和副肿瘤疾病的细胞微环境的改变。PPG的相互作用性质将提供基本假设,以支持翻译研究,以确定针对逆转录病毒诱导的淋巴瘤的治疗干预,并完善动物模型,以确定逆转录病毒诱导的癌症的分子决定因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL D. LAIRMORE其他文献

MICHAEL D. LAIRMORE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL D. LAIRMORE', 18)}}的其他基金

Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
  • 批准号:
    7937326
  • 财政年份:
    2009
  • 资助金额:
    $ 215.85万
  • 项目类别:
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair
HTLV-1 p30 转录和 DMA 修复机制
  • 批准号:
    7383661
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration
核心 A:管理/预算/运营和生物统计学
  • 批准号:
    8376230
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    6740097
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    7458547
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
RESEARCH TRAINING FOR VETERINARY STUDENTS
兽医学生研究培训
  • 批准号:
    6899259
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation and Disease- Competing Supplement
淋巴细胞转化和疾病竞争补充剂的逆转录病毒模型
  • 批准号:
    7016237
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    7059991
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair
HTLV-1 p30 转录和 DMA 修复机制
  • 批准号:
    8079527
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    6889106
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:

相似国自然基金

Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    合作创新研究团队
新型手性NAD(P)H Models合成及生化模拟
  • 批准号:
    20472090
  • 批准年份:
    2004
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
  • 批准号:
    7937326
  • 财政年份:
    2009
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
  • 批准号:
    8300002
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    6740097
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    7458547
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation and Disease- Competing Supplement
淋巴细胞转化和疾病竞争补充剂的逆转录病毒模型
  • 批准号:
    7016237
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    7059991
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    6889106
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
  • 批准号:
    6604623
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
  • 批准号:
    8079535
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
  • 批准号:
    7643986
  • 财政年份:
    2003
  • 资助金额:
    $ 215.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了